Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GPIIb/IIIa' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 687 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tomita, Y; Tanahashi, N; Tomita, M; Itoh, Y; Yokoyama, M; Takeda, H; Schiszler, I; Fukuuchi, Y
      Role of platelet glycoprotein IIb/IIIa in ADP-activated platelet adhesion to aortic endothelial cells in vitro: observation with video-enhanced contrast microscopy

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    2. Nicholson, CD; Lensing, AWA
      Old antithrombotics: ready to retire?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Mattson, JC
      Platelet polymorphisms and arterial thrombotic disease

      JOURNAL OF CLINICAL LIGAND ASSAY
    4. Latour-Perez, J
      Risks and benefits of glycoprotein IIb/IIIa antagonists in acute coronary syndrome

      ANNALS OF PHARMACOTHERAPY
    5. Junghans, U; Seitz, RJ; Aulich, A; Freund, HJ; Siebler, M
      Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: An open pilot study

      CEREBROVASCULAR DISEASES
    6. Sherman, DG
      Antithrombotic therapy in the acute phase: New approaches

      CEREBROVASCULAR DISEASES
    7. Bornstein, NM
      Antiplatelet drugs: How to select them and possibilities of combined treatment

      CEREBROVASCULAR DISEASES
    8. Hantgan, RR; Rocco, M; Nagaswami, C; Weisel, JW
      Binding of a fibrinogen mimetic stabilizes integrin alpha IIb beta 3's open conformation

      PROTEIN SCIENCE
    9. Vinciguerra, C; Bordet, JC; Beaune, G; Grenier, C; Dechavanne, M; Negrier, C
      Description of 10 new mutations in platelet glycoprotein IIb (alpha IIb) and glycoprotein IIIa (beta 3) genes

      PLATELETS
    10. Dabadie, M; Valli, N; Jacobin, MJE; Laroche-Traineau, J; Barat, JL; Ducassou, D; Nurden, AT; Clofent-Sanchez, G
      Characterisation, cloning and sequencing of a conformation-dependent monoclonal antibody to the alpha(IIb)beta(3) integrin: interest for use in thrombus detection

      PLATELETS
    11. Storey, RF
      The P2Y(12) receptor as a therapeutic target in cardiovascular disease

      PLATELETS
    12. Proimos, G
      Platelet aggregation inhibition with glycoprotein IIb-IIIa inhibitors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    13. Smith, BS; Gandhi, PJ
      Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins andglycoprotein IIb/IIIa receptor antagonists in renal failure

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    14. Zhang, YH; Chung, KH; Ryu, CK; Ko, MH; Lee, MK; Yun, YP
      Antiplatelet effect of 2-chloro-3-(4-acetophenyl)-amino-1,4-naphthoquinone(NQ301): A possible mechanism through inhibition of intracellular Ca2+ mobilization

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    15. Mine, S; Fujisaki, T; Suematsu, M; Tanaka, Y
      Activated platelets and endothelial cell interaction with neutrophils under flow conditions

      INTERNAL MEDICINE
    16. Zhang, YH; Chung, KH; Ryu, CK; Lee, YH; Kim, TJ; Song, YS; Hwang, KA; Yun, YP
      Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)amino-1,4-naphthoquinone (NQ304), an antithrombotic agent

      PHARMACOLOGY & TOXICOLOGY
    17. Renner, W; Winkler, M; Hoffmann, C; Koppel, H; Seinost, G; Brodmann, M; Pilger, E
      The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with deep venous thrombosis

      INTERNATIONAL ANGIOLOGY
    18. Salvati, F; Liani, M
      Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    19. Rossi, F; Rossi, E; Pareti, FI; Colli, S; Tremoli, E; Gallo, L
      In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion

      HAEMATOLOGICA
    20. Schror, K
      Pathophysiology of platelet activation and pharmacology of GPIIb/IIIa antagonists

      HERZ
    21. Nordt, TK; Peter, K; Bode, C
      GPIIb/IIIa blockers for optimizing thrombolysis in acute myokardial infarction

      HERZ
    22. Marques, JA; George, JK; Smith, IJ; Bhakta, V; Sheffield, WP
      A barbourin-albumin fusion protein that is slowly cleared in vivo retains the ability to inhibit platelet aggregation in vitro

      THROMBOSIS AND HAEMOSTASIS
    23. Phillips, DR; Nannizzi-Alamio, L; Prasad, KSS
      beta 3 tyrosine phosphorylation in alpha IIb beta 3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling

      THROMBOSIS AND HAEMOSTASIS
    24. Woodside, DG; Liu, S; Ginsberg, MH
      Integrin activation

      THROMBOSIS AND HAEMOSTASIS
    25. Sassoli, PM; Emmell, EL; Tam, SH; Trikha, M; Zhou, Z; Jordan, RE; Nakada, MT
      7E3 F(ab ')(2), an effective antagonist of rat alpha IIb beta 3 and alpha v beta 3, blocks in vivo thrombus formation and in vitro angiogenesis

      THROMBOSIS AND HAEMOSTASIS
    26. Savi, P; Zamboni, G; Rescanieres, O; Herbert, JM
      Studies on the binding of H-3-SR121566, an inhibitor of Gp IIb-IIIa activation

      THROMBOSIS AND HAEMOSTASIS
    27. Bennett, JS; Mousa, S
      Platelet function inhibitors in the year 2000

      THROMBOSIS AND HAEMOSTASIS
    28. Marciniak, SJ; Jordan, RE; Mascelli, MA
      Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban

      THROMBOSIS AND HAEMOSTASIS
    29. Kosugi, S; Tomiyama, Y; Honda, S; Kashiwagi, H; Shiraga, M; Tadokoro, S; Kiyoi, T; Kurata, Y; Matsuzawa, Y
      Anti-alpha(v)beta(3) antibodies in chronic immune thrombocytopenic purpura

      THROMBOSIS AND HAEMOSTASIS
    30. Klinkhardt, U; Graff, J; Westrup, D; Kirchmaier, CM; Esslinger, HU; Breddin, HK; Harder, S
      Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    31. Tanahashi, N; Fukuuchi, Y; Tomita, M; Tomita, Y; Inoue, K; Satoh, H; Abe, T
      Adhesion of adenosine diphosphate-activated platelets to human brain microvascular endothelial cells under flow in vitro is mediated via GPIIb/IIIa

      NEUROSCIENCE LETTERS
    32. Boudreaux, MK; Lipscomb, DL
      Clinical, biochemical, and molecular aspects of Glanzmann's thrombastheniain humans and dogs

      VETERINARY PATHOLOGY
    33. Storey, RF
      Clinical experience with antithrombotic drugs acting on purine receptor pathways

      DRUG DEVELOPMENT RESEARCH
    34. Plancon, S; Morel-Kopp, MC; Schaffner-Reckinger, E; Chen, P; Kieffer, N
      Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alpha IIb or beta 3 allows the expression of a fully functional integrin alpha IIIbbeta 3: effect of beta 3(GFP) on alpha IIb beta 3 ligand binding

      BIOCHEMICAL JOURNAL
    35. Schwippert-Houtermans, B; Strapatsakis, S; Roesen, P; Tschoepe, D
      Evaluation of an antibody-based genotype classification of the platelet fibrinogen receptor (GPIIb/IIIa)

      CYTOMETRY
    36. Salter, JW; Krieglstein, CF; Issekutz, AC; Granger, DN
      Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    37. Hantgan, RR; Stahle, M; Del Gaizo, V; Adams, M; Lasher, T; Jerome, WG; McKenzie, M; Lyles, DS
      alpha IIb's cytoplasmic domain is not required for ligand-induced clustering of integrin alpha IIb beta 3

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    38. Suvire, FD; Rodriguez, AM; Mak, ML; Papp, JG; Enriz, RD
      Binding mechanism of RGD and its mimetics to receptor GPIIb/IIIa. A theoretical study

      JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    39. Qureshi, AI; Ali, Z; Suri, MFK; Kim, SH; Fessler, RD; Ringer, AJ; Guterman, LR; Hopkins, LN
      Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement

      NEUROSURGERY
    40. Broberg, M; Nygren, H
      Von Willebrand factor, a key protein in the exposure of CD62P on platelets

      BIOMATERIALS
    41. Peerschke, EIB; Ghebrehiwet, B
      Human blood platelet gClqR/p33

      IMMUNOLOGICAL REVIEWS
    42. Zokai, K; Piazolo, L; Harenberg, J
      Effect of thrombin inhibitors and a glycoprotein IIb/IIIa receptor antagonist in an ex vivo human experimental thrombosis model

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    43. Bennett, JS
      Novel platelet inhibitors

      ANNUAL REVIEW OF MEDICINE
    44. Damiano, BP; Mitchell, JA; Giardino, E; Corcoran, T; Haertlein, BJ; de Garavilla, L; Kauffman, JA; Hoekstra, WJ; Maryanoff, BE; Andrade-Gordon, P
      Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonist

      THROMBOSIS RESEARCH
    45. Mousa, SA; Forsythe, MS
      Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography

      THROMBOSIS RESEARCH
    46. Ozsavci, D; Yardimci, T; Demirel, GY; Uras, F; Hekim, N; Ulutin, ON
      Apo A-I binding to platelets detected by flow cytometry

      THROMBOSIS RESEARCH
    47. Erhardt, JA; Ohlstein, EH; Toomey, JR; Gabriel, MA; Willette, RN; Yue, TL; Barone, FC; Parsons, AA
      Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban

      THROMBOSIS RESEARCH
    48. Peter, K; Schwarz, M; Nordt, T; Bode, C
      Intrinsic activating properties of GP IIb/IIIa blockers

      THROMBOSIS RESEARCH
    49. Alfon, J; de Arriba, AF; Gomez-Casajus, LA; Merlos, M
      Alternative binding assay of GP IIb/IIIa antagonists with a nonradioactivelabeling method of platelets

      THROMBOSIS RESEARCH
    50. Rebello, SS; Kasiewski, CJ; Bentley, RG; Morgan, SR; Chu, V; Bostwick, JS; Klein, SI; Perrone, MH; Leadley, RJ
      Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs

      THROMBOSIS RESEARCH
    51. Harder, S; Klinkhardt, U; Graff, J; Westrup, D; Kirchmaier, CM; Glusa, E; Mascelli, MA; Marciniak, SJ; Just, A; Losche, W; Breddin, HK
      In vitro dose response to different GPIIb/IIIa-antagonists: Inter-laboratory comparison of various platelet function tests

      THROMBOSIS RESEARCH
    52. Kageyama, S; Yamamoto, H; Nakazawa, H; Yoshimoto, R
      Anti-human vWF monoclonal antibody, AJvW-2 fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs

      THROMBOSIS RESEARCH
    53. Horisawa, S; Kaneko, M; Sakurama, T
      Protective effects of SM-20302, an orally active GPIIb/IIIa antagonist, inan ADP/epinephrine-induced guinea pig model of transient cerebral ischemia

      THROMBOSIS RESEARCH
    54. Dickfeld, T; Ruf, A; Pogatsa-Murray, G; Muller, I; Engelmann, B; Taubitz, W; Fischer, J; Meier, O; Gawaz, M
      Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists

      THROMBOSIS RESEARCH
    55. Lee, I; Marchant, RE
      Force measurements on the molecular interactions between ligand (RGD) and human platelet alpha(IIb) beta(3) receptor system

      SURFACE SCIENCE
    56. Worsley, DF; Alavi, A
      Radionuclide imaging of acute pulmonary embolism

      RADIOLOGIC CLINICS OF NORTH AMERICA
    57. Chew, DP; Roffi, M; Topol, EJ
      Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes

      PROGRESS IN CARDIOVASCULAR DISEASES
    58. Horton, MA
      Integrin antagonists as inhibitors of bone resorption: implications for treatment

      PROCEEDINGS OF THE NUTRITION SOCIETY
    59. Li, RH; Babu, CR; Lear, JD; Wand, AJ; Bennett, JS; DeGrado, WF
      Oligomerization of the integrin alpha llb beta 3: Roles of the transmembrane and cytoplasmic domains

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    60. Hansen, RJ; Balthasar, JP
      Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: A quantitative rat model of immune thrombocytopenic purpura

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    61. Stilz, HU; Guba, W; Jablonka, B; Just, M; Klingler, O; Konig, W; Wehner, V; Zoller, G
      Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold

      JOURNAL OF MEDICINAL CHEMISTRY
    62. Sulyok, GAG; Gibson, C; Goodman, SL; Holzemann, G; Wiesner, M; Kessler, H
      Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective alpha v beta 3 integrin antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    63. Forsyth, CB; Solovjov, DA; Ugarova, TP; Plow, EF
      Integrin alpha(M)beta(2)-mediated cell migration to fibrinogen and its recognition peptides

      JOURNAL OF EXPERIMENTAL MEDICINE
    64. Osdoit, S; Rosa, JP
      Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    65. Xing, BD; Jedsadayanmata, A; Lam, SCT
      Localization of an integrin binding site to the C terminus of talin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    66. Kamata, T; Tieu, KK; Irie, A; Springer, TA; Takada, Y
      Amino acid residues in the alpha(IIb) subunit that are critical for ligandbinding to integrin alpha(IIb)beta(3) are clustered in the beta-propeller model

      JOURNAL OF BIOLOGICAL CHEMISTRY
    67. Rodrigues, RG; Guo, NH; Zhou, LG; Sipes, JM; Williams, SB; Templeton, NS; Gralnick, HR; Roberts, DD
      Conformational regulation of the fibronectin binding and alpha(3)beta(1) integrin-mediated adhesive activities of thrombospondin-1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    68. Reddy, KB; Bialkowska, K; Fox, JEB
      Dynamic modulation of cytoskeletal proteins linking integrins to signalingcomplexes in spreading cells - Role of skelemin in initial integrin-induced spreading

      JOURNAL OF BIOLOGICAL CHEMISTRY
    69. Ginsberg, MH; Yaspan, B; Forsyth, J; Ulmer, TS; Campbell, ID; Slepak, M
      A membrane-distal segment of the integrin alpha(IIb) cytoplasmic domain regulates integrin activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    70. Soslau, G; Class, R; Morgan, DA; Foster, C; Lord, ST; Marchese, P; Ruggeri, ZM
      Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib

      JOURNAL OF BIOLOGICAL CHEMISTRY
    71. Zolotarjova, NI; Hollis, GF; Wynn, R
      Unusually stable and long-lived ligand-induced conformations of integrins

      JOURNAL OF BIOLOGICAL CHEMISTRY
    72. Basani, RB; D'Andrea, G; Mitra, N; Vilaire, G; Richberg, M; Kowalska, MA; Bennett, JS; Poncz, M
      RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta 3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    73. Mikkelsson, J; Perola, M; Penttila, A; Goldschmidt-Clermont, PJ; Karhunen, PJ
      The GPIIIa (beta(3) integrin) P1(A) polymorphism in the early development of coronary atherosclerosis

      ATHEROSCLEROSIS
    74. Kawano, K; Hokamura, K; Kondo, K; Ikeda, Y; Suzuki, Y; Umemura, K
      Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding

      EUROPEAN JOURNAL OF PHARMACOLOGY
    75. Frelinger, AL; Furman, MI; Krueger, LA; Barnard, MR; Michelson, AD
      Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation

      CIRCULATION
    76. Chico, TJA; Chamberlain, J; Gunn, J; Arnold, N; Bullens, SL; Gadek, TR; Francis, SE; Bunting, S; Horton, M; Shepherd, L; Lipari, MT; Quan, C; Knolle, J; Stilz, HU; Peyman, A; Crossman, DC
      Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty

      CIRCULATION
    77. Chang, MY; Chen, ST
      Concise synthesis of sibrafiban and lamifiban, two non-peptide fibrinogen receptor (GP IIb/IIIa) antagonists

      JOURNAL OF THE CHINESE CHEMICAL SOCIETY
    78. Kitamura, S; Fukushi, H; Miyawaki, T; Kawamura, M; Terashita, Z; Sugihara, H; Naka, T
      Novel non-peptide GPIIb/IIIa antagonists: Synthesis and biological activities of 2-[4-[2-(4-amidinobenzoylamino)-2-(substituted)acetyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl]acetic acids

      CHEMICAL & PHARMACEUTICAL BULLETIN
    79. Kitamura, S; Fukushi, H; Miyawaki, T; Kawamura, M; Terashita, Z; Naka, T
      Orally active GPIIb/IIIa antagonists: Synthesis and biological activities of masked amidines as prodrugs of 2-[(3S)-4-[(2S)-2-(4-amidinobenzoylanlino)-3-(4-methoxyphenyl)propanoyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl]acetic acid

      CHEMICAL & PHARMACEUTICAL BULLETIN
    80. Mousa, SA; Bozarth, JM; Naik, UP; Slee, A
      Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban

      BRITISH JOURNAL OF PHARMACOLOGY
    81. Yatuv, R; Rosenberg, N; Zivelin, A; Peretz, H; Dardik, R; Trakhtenbrot, L; Seligsohn, U
      Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia

      BLOOD
    82. Hu, WJ; Eaton, JW; Tang, LP
      Molecular basis of biomaterial-mediated foreign body reactions

      BLOOD
    83. Yan, BX; Smith, JW
      Mechanism of integrin activation by disulfide bond reduction

      BIOCHEMISTRY
    84. Rozalski, M; Boncler, M; Golanski, J; Watala, C
      Effects of fibrinogen receptor antagonists GR144053F and aurintricarboxylic acid on platelet activation and degranulation

      BIOCHEMICAL PHARMACOLOGY
    85. Lipscomb, DL; Bourne, C; Boudreaux, MK
      Nucleotide sequence of the canine alpha(IIb) gene from platelet-derived cDNA

      AMERICAN JOURNAL OF VETERINARY RESEARCH
    86. MacDonald, M; Vander Velde, D; Aube, J
      Synthesis and conformation of Gly-Gly dipeptides constrained with phenylalanine-like aminocaproic acid linkers

      ORGANIC LETTERS
    87. Krukonis, ES; Isberg, RR
      Integrin beta(1)-chain residues involved in substrate recognition and specificity of binding to invasin

      CELLULAR MICROBIOLOGY
    88. Dal Pozzo, A; Fagnoni, N; Bergonzi, R; Vanini, L; de Castiglione, R; Aglio, C; Colli, S
      Synthesis and anti-aggregatory activity of linear retro-inverso RGD peptides

      JOURNAL OF PEPTIDE RESEARCH
    89. Bednar, MM
      Stroke: antithrombin versus antiplatelet therapy

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    90. Liu, FQ; Craft, RM; Morris, SA; Carroll, RC
      Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    91. Mousa, SA
      Potential role of platelet glycoprotein IIb/IIIa antagonists in cerebrovascular disorders

      CNS DRUGS
    92. Hilleman, DE
      New approaches to the management of AMI: Fibrinolysis plus GP IIb/IIIa receptor blockade

      FORMULARY
    93. Weksler, BB
      Antiplatelet agents in stroke prevention - Combination therapy: Present and future

      CEREBROVASCULAR DISEASES
    94. Koestenberger, M; Gallistl, S; Cvirn, G; Roschitz, B; Muntean, W
      Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro

      BLOOD COAGULATION & FIBRINOLYSIS
    95. Mousa, SA; Forsythe, M; Bozarth, J; Jin, FQ; Confalone, PN
      Human platelet alpha IIb beta 3 integrin binding affinity end specificity of SJ874: antiplatelet efficacy versus aspirin

      CORONARY ARTERY DISEASE
    96. Sloan, SM; Brown, EB; Liu, QD; Frojmovic, MM
      Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation

      PLATELETS
    97. Wang, W; Borchardt, RT; Wang, B
      Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists

      CURRENT MEDICINAL CHEMISTRY
    98. Mukherjee, D; Moliterno, DJ
      Applications of anti-platelet monitoring in catheterization laboratory

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    99. Jafary, FH; Kimmelstiel, CD
      Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    100. Rebello, SS; Huang, J; Faul, JD; Lucchesi, BR
      Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 00:29:34